[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9203114A - Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen. - Google Patents

Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9203114A
MX9203114A MX9203114A MX9203114A MX9203114A MX 9203114 A MX9203114 A MX 9203114A MX 9203114 A MX9203114 A MX 9203114A MX 9203114 A MX9203114 A MX 9203114A MX 9203114 A MX9203114 A MX 9203114A
Authority
MX
Mexico
Prior art keywords
morfolino
daunorubicin
doxorubicin
derivatives
contain
Prior art date
Application number
MX9203114A
Other languages
English (en)
Inventor
Alberto Bargiotti
Pierangelo Zini
Sergio Penco
Fernando Giuliani
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of MX9203114A publication Critical patent/MX9203114A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MX9203114A 1985-03-22 1992-06-22 Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen. MX9203114A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08507577A GB2172594B (en) 1985-03-22 1985-03-22 New morpholino derivatives of daunorubicin and doxorubicin

Publications (1)

Publication Number Publication Date
MX9203114A true MX9203114A (es) 1992-07-01

Family

ID=10576503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203114A MX9203114A (es) 1985-03-22 1992-06-22 Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen.

Country Status (10)

Country Link
US (1) US4672057A (es)
JP (1) JPS61221194A (es)
BE (1) BE904431A (es)
BG (1) BG60535B2 (es)
BR (1) BR1100255A (es)
CZ (1) CZ419591A3 (es)
DE (1) DE3609052C2 (es)
GB (1) GB2172594B (es)
HK (1) HK37392A (es)
MX (1) MX9203114A (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3823224A1 (de) * 1988-07-08 1990-01-11 Behringwerke Ag Morpholino-derivate der rhodomycine, verfahren zu ihrer herstellung und ihre verwendung
GB8905668D0 (en) * 1989-03-13 1989-04-26 Erba Carlo Spa New 3'-(4-morpholinyl)-and 3'-(2-methoxy-4-morpholinyl)-anthracycline derivatives
DE69028610T2 (de) * 1989-12-19 1997-02-06 Pharmacia S.P.A., Mailand/Milano Chirale 1,5-diiodo-2-methoxy oder benzyloxy Zwischenprodukte
US5304687A (en) * 1989-12-19 1994-04-19 Farmitalia Carlo Erba S.R.L. Morpholinyl derivatives of doxorubicin and process for their preparation
GB9019933D0 (en) * 1990-09-12 1990-10-24 Erba Carlo Spa 13-dihydro-3'-(2-alkoxy-4-morphlinyl)anthracyclines
GB9019934D0 (en) * 1990-09-12 1990-10-24 Erba Carlo Spa 2-hydroxy-and 2-acyloxy-4-morpholinyl anthracyclines
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates
US5776458A (en) * 1990-12-05 1998-07-07 Pharmacia & Upjohn S.P.A. Anthracycline-conjugates
GB9028105D0 (en) * 1990-12-27 1991-02-13 Erba Carlo Spa Process for the preparation of substituted benzofuran derivatives
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9909925D0 (en) 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
WO2001049698A1 (en) * 1999-12-29 2001-07-12 Immunogen, Inc. Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
US20040038904A1 (en) * 2002-05-21 2004-02-26 Angela Ogden Method of treating multiple sclerosis
WO2004082579A2 (en) * 2003-03-18 2004-09-30 Pharmacia Italia S.P.A. Nemorubicin as radiosensitizer in combination with radiation therapy against tumors
EP1610763A2 (en) * 2003-03-31 2006-01-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Stable liposomes or micelles comprising a sphingolipid and a peg-lipopolymer
EP1817004A2 (en) * 2004-11-15 2007-08-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Combination therapy associating preferably a ceramide with a cytotoxic drug
JP4513765B2 (ja) * 2005-04-15 2010-07-28 日本ビクター株式会社 電気音響変換器
EP2049530A2 (en) * 2006-07-12 2009-04-22 Nerviano Medical Sciences S.r.l. Crystalline nemorubicin hydrochloride
EP2109462A1 (en) * 2007-01-29 2009-10-21 Nerviano Medical Sciences S.r.l. Antitumor combination comprising a morpholinyl anthracycline and an antibody
EP2152236B1 (en) 2007-05-11 2015-09-02 Nerviano Medical Sciences S.r.l. Pharmaceutical composition of an anthracycline
WO2009016072A2 (en) * 2007-08-02 2009-02-05 Nerviano Medical Sciences S.R.L. A morpholinyl anthracycline derivative combined with protein kinase inhibitors
US8742076B2 (en) 2008-02-01 2014-06-03 Genentech, Inc. Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
US20110021517A1 (en) * 2008-02-26 2011-01-27 Nerviano Medical Sciences S.R.L. Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents
TWI461428B (zh) 2008-07-15 2014-11-21 Genentech Inc 蔥環黴素衍生結合物，其製備方法及作為抗腫瘤化合物之用途
JP2013530993A (ja) 2010-07-02 2013-08-01 アンジオケム インコーポレーテッド 治療用コンジュゲートのための短く且つｄ−アミノ酸を含有するポリペプチドおよびその使用
EP3351559A3 (en) 2010-11-08 2018-10-31 F. Hoffmann-La Roche AG Subcutaneously administered anti-il-6 receptor antibody
KR101897307B1 (ko) 2010-12-02 2018-09-10 네르비아노 메디칼 사이언시스 에스.알.엘. 모르폴리닐 안트라사이클린 유도체의 제조 방법
EP2825206A1 (en) 2012-03-16 2015-01-21 The Johns Hopkins University Controlled release formulations for the delivery of hif-1 inhibitors
KR101640912B1 (ko) * 2014-07-03 2016-07-20 현대자동차주식회사 고온 저마찰성 코팅층 및 이의 제조방법
WO2016040825A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
EP4180061A1 (en) 2021-11-10 2023-05-17 Nerviano Medical Sciences S.r.l. Anthracycline derivative linker reagents, antibody-drug conjugates and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1003383A (es) *
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin

Also Published As

Publication number Publication date
BG60535B2 (bg) 1995-07-28
GB2172594A (en) 1986-09-24
JPS61221194A (ja) 1986-10-01
DE3609052A1 (de) 1986-09-25
US4672057A (en) 1987-06-09
HK37392A (en) 1992-06-04
DE3609052C2 (de) 1994-10-27
GB2172594B (en) 1988-06-08
GB8507577D0 (en) 1985-05-01
BR1100255A (pt) 2002-04-02
BE904431A (fr) 1986-07-16
JPH0482160B2 (es) 1992-12-25
CZ419591A3 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
MX9203114A (es) Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen.
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
MX9203040A (es) Derivados de quinona y composicion farmaceutica que los contiene.
MX9203226A (es) Derivados de fenetanolamina y composicion farmaceutica que los contiene.
MX9202851A (es) Derivados de fosfato de los glucosidos de 4-desmetilepipodofilotoxina y composicion farmaceutica que los contiene.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
MX9202910A (es) Nuevos derivados de dihidropiridina y composicion farmaceutica que los contiene.
MX9203177A (es) Derivados de 1-fluorofenilbutil-4-(2-pirimidinil)piperazina y composiciones farmaceuticas que los contienen.
MX9202289A (es) Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9205280A (es) Derivados de benzanilida, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IT1186779B (it) Composizioni farmaceutiche contenenti glicosidi antraciclinidi
MX9203108A (es) Compuestos de di-t-butilfenol y composiciones que los contienen.
MX9204563A (es) Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende.
MX9202848A (es) Complejos antibioticos designados bbm-2478a y bbm-2478by composiciones farmaceuticas que los contienen.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
MX9203628A (es) Compuestos florados de benciltriazol y composiciones farmaceuticas que los contienen.
PT84023B (pt) Processo para a preparacao de novos derivados da 1-benzeno-sulfonil-2-oxo-alcoxi-pirrolidina e de composicoes farmaceuticas que os contem
MX9202763A (es) Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene.
MX9203639A (es) 3-fenoxi-1-azetidincarboxamidas y composiciones farmaceuticas que las contienen.
MX9204395A (es) Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9203613A (es) Derivados de adenosina y composiciones farmaceuticas que los contienen.
MX174530B (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.